VRPX

Virpax Pharmaceuticals, Inc. Common Stock

Delisted

VRPX was delisted on the 3rd of April, 2025.

18 hedge funds and large institutions have $973K invested in Virpax Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$11.9K
2 +$9.09K
3 +$7.89K
4
SG
StoneX Group
New York
+$7.22K
5
UBS Group
UBS Group
Switzerland
+$3.44K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$615K
2
$111K
3
$62.7K
4
$60K
5
$41K
6
$11.9K
7
$10.6K
8
$10K
9
$9.47K
10
$9.09K
11
$7.89K
12
$7.35K
13
$7.22K
14
$6.22K
15
$3K
16
$669
17
$289
18
$77
19
$37